Dr. Reddy's Laboratories Limited (DRREDDY.NS)
- Previous Close
5,957.15 - Open
6,000.00 - Bid --
- Ask --
- Day's Range
5,880.80 - 6,000.00 - 52 Week Range
4,384.05 - 6,505.90 - Volume
342,598 - Avg. Volume
394,163 - Market Cap (intraday)
989.615B - Beta (5Y Monthly) 0.34
- PE Ratio (TTM)
18.98 - EPS (TTM)
313.19 - Earnings Date May 7, 2024
- Forward Dividend & Yield 40.00 (0.67%)
- Ex-Dividend Date Jul 11, 2023
- 1y Target Est
5,898.70
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
www.drreddys.com25,863
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: DRREDDY.NS
Performance Overview: DRREDDY.NS
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DRREDDY.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DRREDDY.NS
Valuation Measures
Market Cap
989.58B
Enterprise Value
937.08B
Trailing P/E
18.97
Forward P/E
19.46
PEG Ratio (5yr expected)
4.70
Price/Sales (ttm)
3.65
Price/Book (mrq)
3.69
Enterprise Value/Revenue
3.45
Enterprise Value/EBITDA
11.04
Financial Highlights
Profitability and Income Statement
Profit Margin
19.24%
Return on Assets (ttm)
12.38%
Return on Equity (ttm)
21.39%
Revenue (ttm)
271.3B
Net Income Avi to Common (ttm)
52.21B
Diluted EPS (ttm)
313.19
Balance Sheet and Cash Flow
Total Cash (mrq)
72.55B
Total Debt/Equity (mrq)
7.41%
Levered Free Cash Flow (ttm)
23.21B